CSRxP Applauds Trump Administration’s Focus on Lowering Prescription Drug Prices

We applaud President Trump for making the out-of-control prices of prescription drugs a priority in his Administration.

Read more

CSRxP on PhRMA’s Multimillion-Dollar PR Campaign

“No amount of advertising will make hardworking families forget the consequences of their out-of-control drug costs.”

Read more

High-Priced Drugs Driving Increased Taxpayer Spending, HHS Report Shows

A new HHS Office of the Inspector General report finds that high-priced prescription drugs are threatening the sustainability of the taxpayer-funded Medicare Part D program.

Read more

Straight Talk for Pharma

The drug industry is front and center in a national dialogue. How do we make sure patients around the world can get the medicines they need? Can we balance costs and the need for innovation? Pharma leaders answer Forbes’ questions – and yours.

Read more